Fluoroquinolone-resistant Neisseria gonorrhoeae:: the inevitable epidemic

被引：13

作者：

Ghanem, KG ^{[1
]}

Giles, JA ^{[1
]}

Zenilman, JM ^{[1
]}

机构：

[1] Johns Hopkins Univ, Bayview Med Ctr, Div Infect Dis, Baltimore, MD 21224 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2005年 / 19卷 / 02期

关键词：

D O I：

10.1016/j.idc.2005.03.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The worldwide incidence of fluoroquinolone-resistant Neisseria gonorrhoeae has increased dramatically in the last few years. Single doses of fluoroquinolones can no longer be used to treat N gonorrhoeae infections acquired in the Far East, parts of the Middle East, the Pacific Islands, and parts of Western Europe and the United States. Although California and Hawaii account for most of the current United States cases, the increased incidence of fluoroquinolone resistance in some high-risk groups independent of geography heralds an imminent spread of drug-resistant strains throughout the rest of the population.

引用

页码：351 / +

页数：17

共 71 条

[11] A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in the Philippines [J].

de los Reyes, MRA ;

Pato-Mesola, V ;

Klausner, JD ;

Manalastas, R ;

Wi, T ;

Tuazon, CU ;

Dallabetta, G ;

Whittington, WLH ;

Holmes, KK .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1313-1318

[12] Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in the Netherlands, 1991 to 1998 [J].

de Neeling, AJ ;

van Santen-Verheuvel, M ;

Spaargaren, J ;

Willems, RJL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) :3184-3185

[13] Fluoroquinolone treatment failure in gonorrhea - Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones [J].

Deguchi, T ;

Saito, I ;

Tanaka, M ;

Sato, K ;

Deguchi, K ;

Yasuda, M ;

Nakano, M ;

Nishino, Y ;

Kanematsu, E ;

Ozeki, S ;

Kawada, Y .

SEXUALLY TRANSMITTED DISEASES, 1997, 24 (05) :247-250

[14] Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV [J].

Deguchi, T ;

Yasuda, M ;

Nakano, M ;

Kanematsu, E ;

Ozeki, S ;

Ishihara, S ;

Saito, I ;

Kawada, Y .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :247-249

[15] High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae [J].

Dewi, BE ;

Akira, S ;

Hayashi, H ;

Ba-Thein, W .

SEXUALLY TRANSMITTED DISEASES, 2004, 31 (06) :353-359

[16] Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000 [J].

Dicker, LW ;

Mosure, DJ ;

Steece, R ;

Stone, KM .

SEXUALLY TRANSMITTED DISEASES, 2004, 31 (05) :259-264

[17] DNA gyrase, topoisomerase IV, and the 4-quinolones [J].

Drlica, K ;

Zhao, XL .

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+

[18] A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin [J].

Ehret, JM ;

Nims, LJ ;

Judson, FN .

SEXUALLY TRANSMITTED DISEASES, 1996, 23 (04) :270-272

[19]

EVANS AJ, 1966, BRIT J VENER DIS, V42, P251

[20] Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002 [J].

Fenton, KA ;

Ison, C ;

Johnson, AP ;

Rudd, E ;

Soltani, M ;

Martin, I ;

Nichols, T ;

Livermore, DM .

LANCET, 2003, 361 (9372) :1867-1869

← 1 2 3 4 5 6 7 8 →